Algorhythm (NASDAQ:RIME – Get Free Report) and Nexalin Technology (NASDAQ:NXL – Get Free Report) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.
Insider and Institutional Ownership
0.7% of Nexalin Technology shares are held by institutional investors. 0.9% of Algorhythm shares are held by insiders. Comparatively, 25.3% of Nexalin Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Algorhythm and Nexalin Technology’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Algorhythm | -115.03% | N/A | -194.35% |
| Nexalin Technology | -2,722.19% | -0.87% | -0.71% |
Risk & Volatility
Valuation and Earnings
This table compares Algorhythm and Nexalin Technology”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Algorhythm | $23.49 million | 0.12 | -$23.26 million | ($5.62) | -0.19 |
| Nexalin Technology | $300,000.00 | 25.11 | -$8.22 million | ($0.51) | -0.72 |
Nexalin Technology has lower revenue, but higher earnings than Algorhythm. Nexalin Technology is trading at a lower price-to-earnings ratio than Algorhythm, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Algorhythm and Nexalin Technology, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Algorhythm | 1 | 1 | 0 | 1 | 2.33 |
| Nexalin Technology | 1 | 0 | 0 | 0 | 1.00 |
Algorhythm currently has a consensus target price of $5.00, indicating a potential upside of 378.47%. Given Algorhythm’s stronger consensus rating and higher possible upside, analysts clearly believe Algorhythm is more favorable than Nexalin Technology.
About Algorhythm
Algorhythm Holdings, Inc., together with its subsidiaries, engages in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings in North America, Australia, the United Kingdom, Europe, and internationally. It offers karaoke products under the Singing Machine brand; licensed karaoke microphone products under the Carpool Karaoke brand; microphone and accessories, and portable Bluetooth microphones under the Party Machine brand; music entertainment singing machines for children under the brand Singing Machine Kids; connected vehicle karaoke devices; and karaoke music subscription services for the iOS and Android platforms, as well as a web-based download store and integrated streaming services for hardware. The company primarily sells its products to retailers, including national chains, warehouse clubs, department stores, lifestyle merchants, specialty stores, and direct mail catalogs and showrooms. The company was formerly known as The Singing Machine Company, Inc. and changed its name to Algorhythm Holdings, Inc. in September 2024. Algorhythm Holdings, Inc. was incorporated in 1982 and is headquartered in Fort Lauderdale, Florida.
About Nexalin Technology
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.
Receive News & Ratings for Algorhythm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algorhythm and related companies with MarketBeat.com's FREE daily email newsletter.
